No Data
No Data
Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing
Noubar Afeyan, Director, on July 10, 2024, sold 15,000 shares in Moderna (MRNA) for $1,756,177. Following the Form 4 filing with the SEC, Afeyan has control over a total of 6,901,164 shares of the
Is Moderna Stock a Buy?
Moderna (NASDAQ: MRNA) went from being an unknown biotech to a household name thanks to its work developing and marketing one of the most successful COVID-19 vaccines.
Moderna, Inc. (NASDAQ:MRNA) Is Favoured by Institutional Owners Who Hold 68% of the Company
Form 144 | Moderna(MRNA.US) Director Proposes to Sell 1.74 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 10, $Moderna(MRNA.US)$ Director NOUBAR B AFEYAN intends to sell 15,000 shares of its common stock on Jul 10, with a total market value of approximately $1.74 million.
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
In a recent development, Flagship Pioneering, the venture capital firm known for backing Moderna (NASDAQ:MRNA) has successfully secured a whopping $3.6 billion in funding.What Happened: Flagship
Redburn Raises Moderna's Price Target to $117 From $116
Moderna (MRNA) has an average outperform rating and a price target range of $62 to $310, according to analysts polled by Capital IQ.Price: 116.68, Change: +0.61, Percent Change: +0.53
No Data